TD Asset Management »

Miragen Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 79k 21.58
2025-06-30 $1.3M 90k 13.98
2025-03-31 $439k 33k 13.48
2024-12-31 $982k 51k 19.17